Satellos Bioscience Inc.
MSLE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421642
No open-market purchases or sales by Satellos Bioscience Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $59.6M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Satellos Bioscience Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +31 vs. Q4 2025
- Shares held
- 7.60M
- +7.60M vs. Q4 2025
- Total value
- $42.8M
- +$42.8M vs. Q4 2025
- New holders
- 31
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MSLE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $59.6M |
| Q1 2026 | 31 | $42.8M |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Satellos Bioscience Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 1 | $6 | 0.00% | +1 | New |
| Federation des caisses Desjardins du Quebec | 19 | $106 | 0.00% | +19 | New |
| UBS Group AG | 28 | $158 | 0.00% | +28 | New |
| MAI Capital Management | 140 | $789 | 0.00% | +140 | New |
| National Bank of Canada | 2,115 | $11.8K | 0.00% | +2,115 | New |
| China Universal Asset Management Co., Ltd. | 6,400 | $36.0K | 0.00% | +6,400 | New |
| Axq Capital, LP | 10,096 | $56.8K | 0.01% | +10,096 | New |
| Propel Bio Management, LLC | 10,145 | $57.1K | 0.04% | +10,145 | New |
| Geode Capital Management, LLC | 11,907 | $67.0K | 0.00% | +11,907 | New |
| Monashee Investment Management LLC | 12,000 | $67.6K | 0.04% | +12,000 | New |
| Royal Bank of Canada | 16,245 | $91.0K | 0.00% | +16,245 | New |
| Jane Street Group, LLC | 19,608 | $110.4K | 0.00% | +19,608 | New |
| Morgan Stanley | 21,183 | $119.3K | 0.00% | +21,183 | New |
| HRT Financial LP | 30,461 | $171.0K | 0.00% | +30,461 | New |
| Citadel Advisors LLC | 42,492 | $239.2K | 0.00% | +42,492 | New |
| Stonepine Capital Management, LLC | 100,000 | $563.0K | 0.50% | +100,000 | New |
| ADAR1 Capital Management, LLC | 222,555 | $1.25M | 0.08% | +222,555 | New |
| Empery Asset Management, LP | 230,100 | $1.30M | 1.56% | +230,100 | New |
| 683 Capital Management, LLC | 230,833 | $1.30M | 0.12% | +230,833 | New |
| Millennium Management LLC | 298,433 | $1.68M | 0.00% | +298,433 | New |
| Saturn V Capital Management LLC | 350,000 | $1.97M | 0.36% | +350,000 | New |
| Adage Capital Partners GP, L.L.C. | 380,354 | $2.14M | 0.00% | +380,354 | New |
| Avidity Partners Management LP | 387,769 | $2.18M | 0.44% | +387,769 | New |
| Soleus Capital Management, L.P. | 414,359 | $2.33M | 0.09% | +414,359 | New |
| Suvretta Capital Management, LLC | 475,000 | $2.67M | 0.07% | +475,000 | New |
| Sphera Funds Management Ltd. | 489,207 | $2.75M | 0.47% | +489,207 | New |
| Woodline Partners LP | 500,432 | $2.82M | 0.01% | +500,432 | New |
| Point72 Asset Management, L.P. | 690,778 | $3.89M | 0.01% | +690,778 | New |
| Vivo Capital, LLC | 813,666 | $4.58M | 0.38% | +813,666 | New |
| Siren, L.L.C. | 892,074 | $5.02M | 0.14% | +892,074 | New |
| Franklin Resources Inc | 938,666 | $5.31M | 0.00% | +938,666 | New |